US panel's thumbs up to Auxilium's Xiaflex in Dupuytren's disease
17 September 2009
Sue Sutter
Auxilium Pharmaceuticals' Xiaflex (collagenase clostridium histolyticum; formerly AA4500) should be approved for the treatment of advanced Dupuytren's disease, the US
FDA's outside experts unanimously recommended on September 16th.
Members of the arthritis advisory panel said collagenase clostridium...
Please Login to read the full article.